Bolt Historical Income Statement
| BOLT Stock | USD 0.64 0.01 1.59% |
Historical analysis of Bolt Biotherapeutics income statement accounts such as Interest Income of 6.5 M, Depreciation And Amortization of 2.5 M or Interest Expense of 1.8 M can show how well Bolt Biotherapeutics performed in making a profits. Evaluating Bolt Biotherapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bolt Biotherapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Bolt Biotherapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bolt Biotherapeutics is a good buy for the upcoming year.
Bolt |
About Bolt Income Statement Analysis
Bolt Biotherapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bolt Biotherapeutics shareholders. The income statement also shows Bolt investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Bolt Biotherapeutics Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bolt Biotherapeutics. It is also known as Bolt Biotherapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Bolt Biotherapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bolt Biotherapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bolt Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Bolt Stock please use our How to Invest in Bolt Biotherapeutics guide.At this time, Bolt Biotherapeutics' Net Interest Income is comparatively stable compared to the past year. Interest Income is likely to gain to about 6.5 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 67.2 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 281K | 2.2M | 6.2M | 6.5M | Net Interest Income | 281K | 2.2M | 6.2M | 6.5M |
Bolt Biotherapeutics income statement Correlations
Click cells to compare fundamentals
Bolt Biotherapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bolt Biotherapeutics income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | 524K | 199K | 281K | 2.2M | 6.2M | 6.5M | |
| Interest Income | 524K | 199K | 281K | 2.2M | 6.2M | 6.5M | |
| Depreciation And Amortization | 377K | 2.5M | 3.7M | 4.9M | 1.9M | 2.5M | |
| Selling General Administrative | 5.2M | 9.1M | 18.4M | 22.9M | 22.5M | 14.7M | |
| Total Revenue | 215K | 231K | 1.3M | 5.7M | 7.9M | 8.3M | |
| Other Operating Expenses | 31.2M | 49.4M | 94.0M | 96.1M | 84.1M | 67.2M | |
| Operating Income | (31.0M) | (49.2M) | (92.8M) | (90.3M) | (76.2M) | (80.0M) | |
| Net Income From Continuing Ops | (30.5M) | (60.7M) | (98.6M) | (88.1M) | (71.3M) | (74.9M) | |
| Ebit | (31.0M) | (51.1M) | (95.3M) | (93.5M) | (76.2M) | (80.0M) | |
| Research Development | 26.0M | 40.4M | 75.7M | 73.1M | 61.5M | 52.5M | |
| Ebitda | (30.6M) | (48.6M) | (91.6M) | (88.7M) | (74.3M) | (78.1M) | |
| Total Operating Expenses | 31.2M | 49.4M | 94.0M | 96.1M | 84.1M | 67.2M | |
| Reconciled Depreciation | 335K | 611K | 1.2M | 1.7M | 1.8M | 1.1M | |
| Income Before Tax | (30.5M) | (60.7M) | (98.6M) | (88.1M) | (69.2M) | (72.7M) | |
| Total Other Income Expense Net | 482K | (11.5M) | (5.8M) | 2.2M | 7.0M | 7.3M | |
| Net Income Applicable To Common Shares | (30.5M) | (60.7M) | (98.6M) | (88.1M) | (79.3M) | (83.3M) | |
| Net Income | (30.0M) | (72.3M) | (104.4M) | (85.9M) | (69.2M) | (72.7M) | |
| Income Tax Expense | (482K) | 11.5M | 5.8M | (2.2M) | 1.7M | 2.2M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bolt Stock Analysis
When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.